Всероссийская GMP-конференция | R-Pharm
R-Pharm

Partner of the conference

R-Pharm

Moscow, Leninskiy prospect, d. 111B
Tel.: +7 (495) 956-79-37, +7 (495) 956-79-38
E-mail: info@rpharm.ru

R-Pharm Group is one of the largest Russian healthcare companies. It was founded in 2001 by Alexey Repik. In 2017 10% of JSC R-Pharm’s shares were acquired by Japanese Corporation Mitsui & Co., Ltd.

The mission of R-Pharm is to increase the accessibility of the most modern pharmaceuticals and medicine technologies for patients in Russia and all over the world.

The staff consists of more than 3,000 highly qualified professionals. The group of companies operates throughout the Russian Federation, CIS member states, USA, Germany, Japan and other countries. There are more than 70 branches and representative offices. R-Pharm’s headquarters are located in Moscow.

R-Pharm specializes in research and development, manufacturing and commercialization of high-tech medicines, laboratory supplies and medical equipment. Various leading medical institutions and organizations are among the clients of the group.

R-Pharm Group owns several state-of-the-art manufacturing sites in Russia and abroad: high-tech packaging and labeling site in Kostroma region, a plant for production of finished dosage forms and biotechnological APS in Yaroslavl, a pilot manufacturing facility in Moscow, a plant for production of solid dosage forms in Illertissen (Germany), a modern research and APS manufacturing site in Rostov. Russian-Azerbaijani pharmaceutical plant in Baku (Azerbaijan) is under construction. In 2018 R-Pharm and Rosatom agreed to create a joint manufacturing plant in Moscow.

R-Pharm has its own research and development facilities, which allow it to conduct various activities in partnership with the leading Russian and foreign academic institutes. The research pipeline consists of more than 20 own and in-licensed products.

R-pharm signed numerous agreements on manufacturing localization, technology transfer and licensing with the biggest pharmaceutical companies from all over the world.

The product portfolio of the group includes medicines from various therapeutic areas: oncological, hematologic, cardiological, immunological, antibacterial, antiviral, including HIV therapy, pharmaceuticals used during and after organ transplantation, treatment of multiple sclerosis, hemophilia, as well as muscle relaxants, contrast agents and anesthetics.